These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6149588)

  • 1. Low levels of somatostatin in human CSF mark depressive episodes.
    Agren H; Lundqvist G
    Psychoneuroendocrinology; 1984; 9(3):233-48. PubMed ID: 6149588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Life at risk: markers of suicidality in depression.
    Agren H
    Psychiatr Dev; 1983; 1(1):87-103. PubMed ID: 6201842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CSF somatostatin and abnormal response to dexamethasone administration in schizophrenic and depressed patients.
    Doran AR; Rubinow DR; Roy A; Pickar D
    Arch Gen Psychiatry; 1986 Apr; 43(4):365-9. PubMed ID: 2869743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purine and monoamine metabolites in cerebrospinal fluid: parallel purinergic and monoaminergic activation in depressive illness?
    Niklasson F; Agren H; Hällgren R
    J Neurol Neurosurg Psychiatry; 1983 Mar; 46(3):255-60. PubMed ID: 6188805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRH stimulation test and depression.
    Peabody CA; Whiteford HA; Warner MD; Faull KF; Barchas JD; Berger PA
    Psychiatry Res; 1987 Sep; 22(1):21-8. PubMed ID: 2443941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoamine metabolites, corticotropin releasing factor and somatostatin as CSF markers in depressed patients.
    Widerlöv E; Bissette G; Nemeroff CB
    J Affect Disord; 1988; 14(2):99-107. PubMed ID: 2452842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurochemical variables in delusional depression.
    Lykouras E; Markianos M; Malliaras D; Stefanis C
    Am J Psychiatry; 1988 Feb; 145(2):214-7. PubMed ID: 2449085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CSF monoamine metabolites and somatostatin in Alzheimer's disease and major depression.
    Molchan SE; Lawlor BA; Hill JL; Martinez RA; Davis CL; Mellow AM; Rubinow DR; Sunderland T
    Biol Psychiatry; 1991 Jun; 29(11):1110-8. PubMed ID: 1714776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoamine oxidase and cortisol response in depression and schizophrenia.
    Pandey GN; Sharma RP; Janicak PG; Davis JM
    Psychiatry Res; 1992 Oct; 44(1):1-8. PubMed ID: 1461943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Symptom patterns in unipolar and bipolar depression correlating with monoamine metabolites in the cerebrospinal fluid: I. General patterns.
    Agren H
    Psychiatry Res; 1980 Oct; 3(2):211-23. PubMed ID: 6171840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevation of CSF somatostatin concentrations in mania.
    Sharma RP; Bissette G; Janicak PG; Davis JM; Nemeroff CB
    Am J Psychiatry; 1995 Dec; 152(12):1807-9. PubMed ID: 8526251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toward a biochemical classification of depressive disorders IX. DST results and platelet MAO activity.
    Schatzberg AF; Rothschild AJ; Gerson B; Lerbinger JE; Schildkraut JJ
    Br J Psychiatry; 1985 Jun; 146():633-7. PubMed ID: 4016477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet MAO activity and the cortisol response to dexamethasone in major depression.
    Meltzer HY; Lowy MT; Locascio JJ
    Biol Psychiatry; 1988 Jun; 24(2):129-42. PubMed ID: 3390495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychotic and nonpsychotic depressions: II. Platelet MAO activity, plasma catecholamines, cortisol, and specific symptoms.
    Schatzberg AF; Rothschild AJ; Langlais PJ; Lerbinger JE; Schildkraut JJ; Cole JO
    Psychiatry Res; 1987 Feb; 20(2):155-64. PubMed ID: 3575560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine metabolism and disposition in schizophrenic patients. Studies using debrisoquin.
    Maas JW; Contreras SA; Seleshi E; Bowden CL
    Arch Gen Psychiatry; 1988 Jun; 45(6):553-9. PubMed ID: 3377641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal fluid somatostatin and psychiatric illness.
    Rubinow DR
    Biol Psychiatry; 1986 Apr; 21(4):341-65. PubMed ID: 2869790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain energy metabolism and blood-brain barrier permeability in depressive patients: analyses of creatine, creatinine, urate, and albumin in CSF and blood.
    Niklasson F; Agren H
    Biol Psychiatry; 1984 Aug; 19(8):1183-206. PubMed ID: 6498242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain purinergic activity linked with depressive symptomatology: hypoxanthine and xanthine in CSF of patients with major depressive disorders.
    Agren H; Niklasson F; Hällgren R
    Psychiatry Res; 1983 Jul; 9(3):179-89. PubMed ID: 6578531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CSF somatostatin in Alzheimer's disease and major depression: relationship to hypothalamic-pituitary-adrenal axis and clinical measures.
    Molchan SE; Hill JL; Martinez RA; Lawlor BA; Mellow AM; Rubinow DR; Bissette G; Nemeroff CB; Sunderland T
    Psychoneuroendocrinology; 1993; 18(7):509-19. PubMed ID: 7903467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CSF somatostatin in patients with Alzheimer's disease, older depressed patients, and age-matched control subjects.
    Sunderland T; Rubinow DR; Tariot PN; Cohen RM; Newhouse PA; Mellow AM; Mueller EA; Murphy DL
    Am J Psychiatry; 1987 Oct; 144(10):1313-6. PubMed ID: 2889377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.